Nalaganje...
Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
Multidrug resistance (MDR) triggered by ATP binding cassette (ABC) transporter such as ABCB1, ABCC1, ABCG2 limited successful cancer chemotherapy. Unfortunately, no commercial available MDR modulator approved by FDA was used in clinic. Tyrosine kinase inhibitors (TKIs) have been administrated to fig...
Shranjeno v:
| izdano v: | Mol Cancer |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5817862/ https://ncbi.nlm.nih.gov/pubmed/29455646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-018-0775-3 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|